Filter by: patients
What is Meloxicam?

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve the symptoms of osteoarthritis and rheumatoid arthritis.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Pain 152 37 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Fibromyalgia 136 37 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Inflammation 84 18 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_cant_tell
Other 34 7 Efficacy_moderate Efficacy_slight Efficacy_none
Pain, Inflamation, muscle spasms 33 14 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none
Arthritis pain 29 10 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none

See all 504 patients currently taking Meloxicam

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
19
Moderate
23
Mild
31
None
71

Reported Dosages

Frequently reported dosages based on patients currently taking Meloxicam. See all 17 dosages

  7.5mg as needed daily 7.5mg/5mL as needed 15mg as needed 7.5 mg weekly 7.5 mg/5 mL daily 7.5 mg daily 2 x 7.5 mg/5 mL daily 15 mg daily 30 mg daily
  15 Number of Patients: 15 2 Number of Patients: 2 5 Number of Patients: 5 14 Number of Patients: 14 1 Number of Patients: 1 42 Number of Patients: 42 75 Number of Patients: 75 26 Number of Patients: 26 314 Number of Patients: 314 14 Number of Patients: 14  

Reported Stop Reasons

Why Patients Stopped Taking Meloxicam (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 43   Did not seem to work: 34%
Doctor's advice 33   Doctor's advice: 26%
Side effects too severe 32   Side effects too severe: 25%
Other 21   Other: 17%
Course of treatment ended 11   Course of treatment ended: 9%
Personal research 5   Personal research: 4%
Change in health plan coverage 5   Change in health plan coverage: 4%
Not indicated 5   Not indicated: 4%
Expense 4   Expense: 3%

See all 127 patients who’ve stopped taking Meloxicam

Currently Taking Meloxicam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Stopped Taking Meloxicam

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Adherence of Meloxicam

Always
109 76%
Usually
17 12%
Sometimes
11 8%
Never
7 5%

Burden

Difficulty being on treatment

Burden of Meloxicam

Very
9 6%
Somewhat
4 3%
A little
18 13%
Not at all
113 78%

Cost

Paid out of pocket

Cost of Meloxicam

$200+
0 0%
$100-199
0 0%
$50-99
1 1%
$25-49
9 10%
< $25
78 89%

See more information, including instructions, precautions, side effects, and interactions.

Report created on February 12, 2012.